FINHUB Insights

INCY · Q3 FY25 · Jul 1 – Sep 30, 2025

Incyte Q3 FY25: where the revenue came from and where it went

Incyte Q3 FY25: revenue $1.4B (+20% year over year). Net profit $0.42B. Largest cohort Jakafi $0.8B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jul 1 – Sep 30, 2025
Reported
Oct 28, 2025 10-Q
Sankey diagram of Incyte's income statement for Q3 FY25: revenue of $1.37 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$1.37B +20% year over year
Gross profit$1.27B 93% margin
Operating profit$0.44B 32% margin
Net profit$0.42B 31% margin

The numbers

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
ItemValueShare of revenueYear over year
Revenue 1.37 100% +20%
Jakafi 0.79 58% +7%
Opzelura 0.19 14% +35%
Product royalty 0.17 13% +9%
Niktimvo 0.05 3%
Other 0.05 3%
Milestone & contract 0.05 3% +150%
Minjuvi/monjuvi 0.04 3% +34%
Iclusig 0.04 3% +26%
Cost of revenue−0.107%
Gross profit1.2793% margin+0pp
R&D−0.4936%−13pp
SG&A−0.3324%−3pp
Operating profit0.4432% margin+20pp
Tax−0.06
Net profit0.4231%+22pp
Filing on EDGAR More quarters of INCY

Source of the numbers: tables in the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.